Pharmaceutical Practice

Pharmacy Practice is the discipline of pharmacy which involves developing the professional roles of pharmacists. Pharmacy Practice offers practicing pharmacists in-depth useful reviews and research trials and surveys of new drugs and novel therapeutic approaches.

Medication is the most common intervention in health care and plays a vital role in maintaining our health and wellbeing. Evidence suggests that inappropriate use of medicines results in sub-optimal medication outcomes and significant health damage for patients, and it decreases the efficiency and effectiveness of health care systems. Since a long time, the Committee of Experts CD-P-PH/PC has, through a number of activities, initiatives and legal instruments, actively contributed to the development and implementation of quality and safety standards to advance the appropriate and safe use of medications, promote patient-centred care and ensure that patients obtain the best possible outcome from their medicine”

The model is “fit for purpose” across multiple countries and includes two components making up the umbrella term “pharmaceutical practice”. The first component is the four conceptual dimensions, which outline the disciplines including social and administrative sciences, community pharmacy, clinical pharmacy and pharmaceutical sciences. The second component of the model describes the “acts of practice”: teaching, research and professional advocacy; service and academic enterprise.

In the area of hospital pharmacy, the terms pharmacy practice, clinical pharmacy, pharmacotherapy and public sector pharmacy have all been used interchangeably. Descriptions for community pharmacy have included pharmacy practice, retail pharmacy, community pharmacy, private sector pharmacy, private sector hospital pharmacy and clinical pharmacy practice in community pharmacies.

In the modern clinical microbiology laboratory, rapid diagnostic tests (RDTs) have transformed infectious diseases management by providing more rapid and robust microbiological diagnoses. The advances in the detection of bacteria, viruses, and fungi during the management of these infections not only serve as invaluable guidance in early clinical decision making, but have had significant impact on clinical outcomes, antimicrobial use, and cost savings. In particular, direct-specimen rapid amplification and detection platforms and next-generation sequencing are the 2 major directions in the current explosion of molecular technology.

Submit manuscript at http://www.longdom.org/submissions/pharmaceutical-care-health-systems.html or send as an e-mail attachment to the Editorial Office at heavymetaldis@peerreviewjournal.com

With kind regards,

Nancy Ella

Editorial Manager

Journal of Pharmaceutical Care & Health Systems